Case Study
On-site Treatment of Pharmaceutical Clean-in-Place Wastewater
www.axinewater.com Customer Pain Point A leading pharmaceutical manufacturer operates a facility located in the Northeastern United States that uses an isopropyl alcohol-based (IPA) solvent as part of their reaction vessel wash process. Oxidation of isopropanol via biological and other processes can lead to the formation of acetone in wastewater, an EPA regulated compound under Title 40 pretreatment standards. The customer’s goal was to reduce IPA concentration by 90% in the wastewater utilizing the Axine system as a pretreatment step prior to discharge to the sewer. This would ensure their acetone discharge does not exceed the daily 20.7 mg/L or 8.2 mg/L monthly average regulatory limit at the compliance sampling point. In addition, the Axine system needed to demonstrat